Media
CurveChats, Episode 1
We Need Biological Monitoring
May 14, 2026

In this first episode of CurveChats, our CEO Ritish Patnaik, PhD, explores how the future of chronic care requires improved patient monitoring with CMO Amit Singal, MD, and COO Alice Chen, PhD. This conversation dives into the future of patient monitoring and how blood-based biological testing will transform how patients, physicians, pharma, and insurers manage chronic disease.

You may like
05 Oct 2026
Read
Curve Biosciences Unveils Transformative Results for Liver Disease Monitoring with Its Whole-Body Blood Test™ Powered by Whole-Body Intelligence™
Press Release
09 Jun 2026
Read
Business Wire
Curve Biosciences Unveils Scientific Advisory Board Guiding the Advancement of Whole-Body Intelligence for Chronic Disease
Press Release
01 May 2026
Read
BioTechTV
Curve Biosciences is creating a DNA based blood test to detect and measure chronic illness throughout the body
Article
• by
BioTechTV